Publications
Sort:
Open Access Issue
Seaweed Polysaccharides Fermented by Pediococcus pentosaceus CQFP202447 Improves the Intestinal Flora and Ameliorates Nerve Injury in Mice via the Gut-Brain Axis
Food Science 2025, 46(20): 208-222
Published: 25 October 2025
Abstract PDF (4.1 MB) Collect
Downloads:1
Objective

To investigate the effects of seaweed polysaccharides fermented by Pediococcus pentosaceus CQFP202447 on alleviating antibiotic-induced neuroinflammation and oxidative stress and the regulatory effect on the intestinal flora in mice.

Methods

A mixed antibiotic preparation was used to create a mouse model by intraperitoneal injection. After the experiment, weight-bearing swimming and exhaustive running time, liver index, oxidative and inflammatory indexes of the serum and brain, and intestinal flora composition were measured. The pathological changes of brain tissue were observed by hematoxylin-eosin (HE) staining. The expression of inflammatory pathway genes in the brain and the expression of key intestinal barrier genes were detected by using real-time quantitative polymerase chain reaction (qPCR).

Results

Compared with the model group, P. pentosaceus CQFP202447 and its fermented preparation (PP-PS) significantly prolonged the weight-bearing swimming and running time of mice (P < 0.05), the latter being more effective, while liver index did not change significantly (P > 0.05). HE staining showed that both of them improved the cell morphology of mouse brain tissue, increased the number of cells, and reduced pyknosis. Meanwhile, they reduced the levels of malondialdehyde (MDA), interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) in the serum and brain, and increased the levels of superoxide dismutase (SOD), glutathione (GSH) and IL-10. PP-PS showed more significant effect in down-regulating MDA and TNF-α levels in the serum and in up-regulating SOD and IL-10 levels in brain tissue (P < 0.05). Both CQFP202447 and PP-PS activated and enhanced the gene expression of Akt, Creb, Bdnf, Erk1 in the brain, the latter being more effective in this regard. In addition, they regulated the intestinal flora, changing the α and β diversity, increasing the relative abundance of the beneficial bacteria Muribaculaceae, Akkermansia, Prevotella and Lachnospiraceae, and reducing the relative abundance of the harmful bacterium Desulfovibrio.

Conclusion

P. pentosaceus CQFP202447 and its fermented preparation can reduce antibiotic-induced neuroinflammation and oxidative stress and simultaneously improve the composition of intestinal flora. This study provides a theoretical basis for understanding the role of P. pentosaceus CQFP202447 and its fermented preparation in alleviating neuroinflammation and oxidative stress and promoting intestinal health, thereby providing new ideas for the development of related functional foods.

Open Access Issue
Effect of Lactobacillus fermentum CQPC04 on Reducing Thrombosis and Regulating Intestinal Flora in Mice
Food Science 2023, 44(1): 149-159
Published: 15 January 2023
Abstract PDF (5.7 MB) Collect
Downloads:0

In this study, the effect of 10-day intragastric administration of different concentrations (1 × 108 and 1 × 109 CFU/mL) of Lactobacillus fermentum CQPC04 (LF-CQPC04) suspension at a dose of 0.2 mL/(g mb·d) on blood coagulation, oxidative stress levels, inflammation levels and intestinal microbial composition in a mouse model of thrombosis induced by injecting 0.01 mL/(g mb·d) of 0.2% carrageenan was analyzed. Biochemical kits, hematoxylin-eosin (H&E) staining, and quantitative polymerase chain reaction (qPCR) were used to detect related indicators in serum and tissues, and high-throughput sequencing was used to observe the composition of gut microbiota. The experimental results showed that LF-CQPC04 could shorten the length of black tail, prothrombin time and thrombin time in mice with thrombosis, reduce the blood fibrinogen (FIB) concentration, and increase the activated partial thromboplastin time (APTT). LF-CQPC04 could also reduce malondialdehyde (MDA), tumor necrosis factor (TNF)-α, interleukin (IL)-6, nuclear factor (NF)-κB and IL-1β levels in serum, and increase superoxide dismutase (SOD) and catalase (CAT) activities. H&E staining showedthat LF-CQPC04 could reduce tissue damage caused by tail vein thrombosis. LF-CQPC04 down-regulated the mRNA expression of the NF-κB p65, IL-6, TNF-α and IFN-γ genes in colon tissue, and up-regulated the mRNA expression of the genes encoding copper-zinc superoxide dismutase (Cu/Zn-SOD), manganese superoxide dismutase (Mn-SOD) and CAT. LF-CQPC04 could also down-regulate the mRNA expression of the genes encoding NF-κB p65, intercellular cell adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), and E-selectin in tail vein tissue. The gene sequencing results of gut microbiota showed that LF-CQPC04 could increase the relative abundance of beneficial bacteria such as norank_f_Muribaculaceae, Lactobacillus, Bacteroides, Lachnospiraceae NK4A136, unclassified_f__Lachnospiraceae. These results indicated that LF-CQPC04 could inhibit thrombosis in mice, reduce oxidative stress and intestinal inflammation in mice with thrombosis, and regulate the intestinal flora, and high concentrations of LF-CQPC04 showed more pronounced effects, close to those of the drug heparin.

Total 2